Skip to main content

ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Takeover

  • If you are a current investor in ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) shares and purchased your NASDAQ:ISTA shares prior to March 26, 2012, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

San Diego, March 26, 2012 (Shareholders Foundation) -- The announcement by ISTA Pharmaceuticals, Inc. that its board of directors agreed a takeover of ISTA Pharmaceuticals, Inc. by Bausch + Lomb for $9.10 per NASDAQ:ISTA share prompted an investigation for investors in ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) shares concerning whether the offer to acquire ISTA Pharmaceuticals, Inc. an...



You must register (for free) or login to view the entire investigation.